Your browser doesn't support javascript.
loading
Clinical and neuroimaging characteristics of clinically unclassifiable primary progressive aphasia.
Utianski, Rene L; Botha, Hugo; Martin, Peter R; Schwarz, Christopher G; Duffy, Joseph R; Clark, Heather M; Machulda, Mary M; Butts, Alissa M; Lowe, Val J; Jack, Clifford R; Senjem, Matthew L; Spychalla, Anthony J; Whitwell, Jennifer L; Josephs, Keith A.
Afiliação
  • Utianski RL; Department of Neurology, Mayo Clinic, Rochester, MN, USA. Electronic address: Utianski.Rene@mayo.edu.
  • Botha H; Department of Neurology, Mayo Clinic, Rochester, MN, USA.
  • Martin PR; Department of Health Science Research, Mayo Clinic, Rochester, MN, USA.
  • Schwarz CG; Department of Radiology, Mayo Clinic, Rochester, MN, USA.
  • Duffy JR; Department of Neurology, Mayo Clinic, Rochester, MN, USA.
  • Clark HM; Department of Neurology, Mayo Clinic, Rochester, MN, USA.
  • Machulda MM; Department of Psychiatry & Psychology, Mayo Clinic, Rochester, MN, USA.
  • Butts AM; Medical College of Wisconsin, Milwaukee, WI, USA.
  • Lowe VJ; Department of Radiology, Mayo Clinic, Rochester, MN, USA.
  • Jack CR; Department of Radiology, Mayo Clinic, Rochester, MN, USA.
  • Senjem ML; Department of Radiology, Mayo Clinic, Rochester, MN, USA.
  • Spychalla AJ; Department of Radiology, Mayo Clinic, Rochester, MN, USA.
  • Whitwell JL; Department of Radiology, Mayo Clinic, Rochester, MN, USA.
  • Josephs KA; Department of Neurology, Mayo Clinic, Rochester, MN, USA.
Brain Lang ; 197: 104676, 2019 10.
Article em En | MEDLINE | ID: mdl-31419589
ABSTRACT
Many patients who meet core/root criteria for Primary Progressive Aphasia (PPA) are not classifiable as a recognized variant and are often excluded from neuroimaging studies. Here, we detail neurological, neuropsychological, speech and language assessments, and anatomic and molecular neuroimaging (MRI, PiB-PET, and FDG-PET) for fifteen (8 female) clinically unclassifiable PPA patients. Median age of onset was 64 years old with median 3 years disease duration at exam. Three patients were amyloid positive on PiB-PET. 14/15 patients had abnormal FDG-PETs with left predominant hypometabolism, affecting frontal, temporal, parietal, and even occipital lobes. Patients had mild to severe clinical presentations. Visualization of the FDG-PETs principal component analysis revealed patterns of hypometabolism similar to those seen in the PPA variants and suggests the brain regions affected in unclassifiable PPA patients are no different from those who are more easily classifiable. These findings may inform future modifications to the diagnostic criteria to improve diagnostic classification.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Encéfalo / Afasia Primária Progressiva / Neuroimagem Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Encéfalo / Afasia Primária Progressiva / Neuroimagem Idioma: En Ano de publicação: 2019 Tipo de documento: Article